A Phase III Double-blind Randomized Placebo-Controlled Study assessing the Efficacy Safety and Tolerability of Idebenone in Patients with Duchenne Muscular Dystrophy Receiving Glucocorticoid Steroids (SIDEROS)
-
- STATUS
- Not Recruiting
Summary
In this study, idebenone will be tested in order to determine the effect it has on breathing on DMD patients receiving Glucocorticoid Steroids compared to placebo (a pill with no drug in it) and to see how well idebenone is tolerated over an 18 months treatment period.
Description
In this study, idebenone will be tested in order to determine the effect it has on breathing on DMD patients receiving Glucocorticoid Steroids compared to placebo (a pill with no drug in it) and to see how well idebenone is tolerated over an 18 months treatment period.
Details
| Condition | Duchenne muscular dystrophy |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX7156 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.